G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas
出版年份 2018 全文链接
标题
G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas
作者
关键词
-
出版物
Cell Death & Disease
Volume 9, Issue 5, Pages -
出版商
Springer Nature
发表日期
2018-04-27
DOI
10.1038/s41419-018-0504-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion
- (2017) Dan Yue et al. NEOPLASIA
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Arginine Demethylation of G3BP1 Promotes Stress Granule Assembly
- (2016) Wei-Chih Tsai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Choosing the right cell line for renal cell cancer research
- (2016) Klaudia K. Brodaczewska et al. Molecular Cancer
- Prognostic value of interleukin-6 and interleukin-6 receptor in organ-confined clear-cell renal cell carcinoma: a 5-year conditional cancer-specific survival analysis
- (2015) Qiang Fu et al. BRITISH JOURNAL OF CANCER
- Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients
- (2015) Lingqiang Min et al. HISTOPATHOLOGY
- Interleukin-6 as an emerging regulator of renal cell cancer
- (2015) Katarzyna Kamińska et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- C1QBP Negatively Regulates the Activation of Oncoprotein YBX1 in the Renal Cell Carcinoma As Revealed by Interactomics Analysis
- (2014) Yong Wang et al. JOURNAL OF PROTEOME RESEARCH
- Interleukin-6 in renal disease and therapy
- (2014) S. A. Jones et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Resveratrol induces apoptosis by directly targeting Ras-GTPase-activating protein SH3 domain-binding protein 1
- (2014) N Oi et al. ONCOGENE
- Downregulation of G3BPs inhibits the growth, migration and invasion of human lung carcinoma H1299 cells by suppressing the Src/FAK-associated signaling pathway
- (2013) H Zhang et al. CANCER GENE THERAPY
- Targeted therapy in metastatic renal carcinoma
- (2013) Jane Mattei et al. CANCER LETTERS
- Integrated molecular analysis of clear-cell renal cell carcinoma
- (2013) Yusuke Sato et al. NATURE GENETICS
- GAP161 targets and downregulates G3BP to suppress cell growth and potentiate cisplaitin-mediated cytotoxicity to colon carcinoma HCT116 cells
- (2012) Hao Zhang et al. CANCER SCIENCE
- Interleukin-6 signaling pathway in targeted therapy for cancer
- (2012) Yuqi Guo et al. CANCER TREATMENT REVIEWS
- Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression
- (2012) Toshiki Oguro et al. EUROPEAN JOURNAL OF CANCER
- Both G3BP1 and G3BP2 contribute to stress granule formation
- (2012) Hideaki Matsuki et al. GENES TO CELLS
- A Novel 19q13 Nucleolar Zinc Finger Protein Suppresses Tumor Cell Growth through Inhibiting Ribosome Biogenesis and Inducing Apoptosis but Is Frequently Silenced in Multiple Carcinomas
- (2012) Y. Cheng et al. MOLECULAR CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The Epidemiology of Renal Cell Carcinoma
- (2011) Börje Ljungberg et al. EUROPEAN UROLOGY
- Arginine methylation of G3BP1 in response to Wnt3a regulates -catenin mRNA
- (2011) R. K. Bikkavilli et al. JOURNAL OF CELL SCIENCE
- Revisiting G3BP1 as a RasGAP Binding Protein: Sensitization of Tumor Cells to Chemotherapy by the RasGAP 317–326 Sequence Does Not Involve G3BP1
- (2011) Alessandro Annibaldi et al. PLoS One
- A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer
- (2010) J-F Rossi et al. BRITISH JOURNAL OF CANCER
- mTOR Complex Component Rictor Interacts with PKC and Regulates Cancer Cell Metastasis
- (2010) F. Zhang et al. CANCER RESEARCH
- Long-term management of patients with metastatic renal cell carcinoma on targeted agents
- (2010) Eric Jonasch et al. Expert Review of Anticancer Therapy
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
- (2009) F. Colotta et al. CARCINOGENESIS
- Targeting Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling in a mouse model of renal carcinoma
- (2009) Z. S. Morris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma
- (2008) Jacob A. Klapper et al. CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started